AccuMed (US) takes over Sensititre (UK):
This article was originally published in Clinica
Executive Summary
Laboratory diagnostic products company AccuMed (US) has purchased Sensititre (UK) and its US assets and operations from Radiometer (Denmark) for an undisclosed amount. Blood gas metre manufacturer Radiometer has wanted to leave the microbiology market for some time and has in the past said it hopes to end up with an extraordinary pre-tax income for the Sensititre operations of $1-2.5 million (see Clinica No 635, p 17). Sensititre produces antimicrobial susceptibility and bacterial identification testing systems based on its microplate technology. It will become part of AccuMed's Microbiology Division which will be headed by Tony DiFranco, formerly Sensititre's vice-president of US operations. AccuMed is a privately-held company in Chicago with annual sales in excess of $5 million.